Literature DB >> 25708201

Oculomotor capture by irrelevant onsets with and without color contrast.

Stefanie I Becker1, Amanda Jane Lewis.   

Abstract

It is widely known that irrelevant onsets (i.e., items appearing in previously empty locations) can automatically capture attention and attract our gaze. Some studies have shown that onset capture is stronger when the onset distractor matches the target feature, indicating that onset capture can be modulated by feature-based (top-down) tuning to the target. However, it is less clear whether and to what extent the perceptual saliency of the distractor can further modulate this effect. This study examined the effects of target similarity, competition between target and distractor, and bottom-up color contrast on the ability of onset distractor to capture the gaze, by varying the color (contrast) and stimulus-onset asynchrony of the onset distractor. The results clearly show that competition and feature-based attention modulate capture by the irrelevant onset to a large extent, whereas bottom-up color contrasts do not modulate onset capture. These results indicate the need to revise current accounts of gaze control.
© 2015 New York Academy of Sciences.

Keywords:  SOA; color contrast; oculomotor capture; onset capture; visual search

Mesh:

Year:  2015        PMID: 25708201     DOI: 10.1111/nyas.12685

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Top-down knowledge modulates onset capture in a feedforward manner.

Authors:  Stefanie I Becker; Amanda J Lewis; Jenna E Axtens
Journal:  Psychon Bull Rev       Date:  2017-04

2.  Oculomotor suppression of abrupt onsets versus color singletons.

Authors:  Owen J Adams; Eric Ruthruff; Nicholas Gaspelin
Journal:  Atten Percept Psychophys       Date:  2022-06-14       Impact factor: 2.199

3.  Top-down modulation of gaze capture: Feature similarity, optimal tuning, or tuning to relative features?

Authors:  Ashley York; Stefanie I Becker
Journal:  J Vis       Date:  2020-04-09       Impact factor: 2.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.